// App-Quantinova.ai

: Impact of Venous Thromboembolism during High Intensity Chemotherapy for Acute Leukemia Patients on Duration of Hospital Stay

Researchers

Presenter

  • Madeline Waldron

Principal Investigators

  • Caitlin Siebenaller

  • Marc Earl

  • Xuefei Jia

  • Hetty E. Carraway

  • Anjali S. Advani

  • Aziz Nazha

  • Aaron T. Gerds

  • Betty K. Hamilton

  • Ronald Sobecks

  • Matt Kalaycio

  • Barb Tripp

  • Brian P. Hobbs

  • Mikkael A. Sekeres

  • Sudipto Mukherjee

Medical Centers

  • Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

  • Department of Medicine, Cleveland Clinic, Cleveland, OH

  • Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

  • Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland, OH

  • Leukemia Program, Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH

  • Cleveland Clinic, Cleveland, OH

  • Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

  • Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH

  • Taussig Cancer Institute Cleveland Clinic, Cleveland, OH

  • Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Acute Leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • PEG-asparaginase

  • Cytarabine liposomal

  • L-Tyrosine

  • Tretinoin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved